Versant Capital Management’s Elevance Health ELV Stock Holding History

Versant Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$518K	Buy	1,340 +212	+19%	+$78.6K	0.05%	284
2026 Q1	$330K	Buy	1,128 +732	+185%	+$241K	0.03%	398
2025 Q4	$139K	Sell	396 -81	-17%	-$27.4K	0.02%	624
2025 Q3	$154K	Buy	477 +128	+37%	+$39.8K	0.02%	559
2025 Q2	$136K	Buy	349 +224	+179%	+$90.1K	0.02%	562
2025 Q1	$54.4K	Buy	125 +54	+76%	+$21.7K	0.01%	824
2024 Q4	$26.2K	Sell	71 -113	-61%	-$47.3K	0.01%	889
2024 Q3	$95.7K	Buy	184 +34	+23%	+$18.2K	0.02%	249
2024 Q2	$81.3K	Buy	150 +77	+105%	+$40.7K	0.02%	245
2024 Q1	$37.9K	Hold	73	–	–	0.01%	332
2023 Q4	$34.4K	Buy	73 +7	+11%	+$3.24K	0.01%	351
2023 Q3	$28.7K	Buy	66 +2	+3%	+$907	0.01%	381
2023 Q2	$28.4K	Buy	64 +2	+3%	+$923	0.01%	397
2023 Q1	$28.5K	Buy	62 +2	+3%	+$952	0.01%	384
2022 Q4	$30.8K	Hold	60	–	–	0.01%	323
2022 Q3	$27K	Sell	60 -1	-2%	-$478	0.01%	346
2022 Q2	$29K	Hold	61	–	–	0.01%	334
2022 Q1	$30K	Sell	61 -1	-2%	-$457	0.01%	362
2021 Q4	$29K	Hold	62	–	–	0.01%	376
2021 Q3	$23K	Buy	62 +1	+2%	+$380	0.01%	420
2021 Q2	$23K	Sell	61 -13	-18%	-$4.97K	0.01%	435
2021 Q1	$27K	Sell	74 -7	-9%	-$2.25K	0.01%	458
2020 Q4	$26K	Buy	81 +2	+3%	+$614	0.01%	423
2020 Q3	$21K	Hold	79	–	–	0.01%	415
2020 Q2	$20K	Hold	79	–	–	0.01%	416
2020 Q1	$17K	Sell	79 -3	-4%	-$818	0.01%	414
2019 Q4	$24K	Sell	82 -27	-25%	-$7.43K	0.01%	399
2019 Q3	$26K	Hold	109	–	–	0.01%	370
2019 Q2	$30K	Sell	109 -100	-48%	-$27.3K	0.01%	331
2019 Q1	$59K	Buy	209 +14	+7%	+$4.05K	0.03%	234
2018 Q4	$51K	Hold	195	–	–	0.02%	242
2018 Q3	$53K	Sell	195 -15	-7%	-$3.89K	0.02%	283
2018 Q2	$49K	Buy	210 +3	+1%	+$695	0.02%	307
2018 Q1	$45K	Sell	207 -10	-5%	-$2.35K	0.02%	326
2017 Q4	$48K	Hold	217	–	–	0.02%	312
2017 Q3	$41K	Sell	217 -10	-4%	-$1.9K	0.02%	315
2017 Q2	$42K	Hold	227	–	–	0.02%	296
2017 Q1	$37K	Hold	227	–	–	0.02%	361
2016 Q4	$32K	Sell	227 -26	-10%	-$3.48K	0.02%	423
2016 Q3	$31K	Buy	253 +12	+5%	+$1.55K	0.02%	409
2016 Q2	$31K	Buy	241 +4	+2%	+$547	0.02%	382
2016 Q1	$32K	Sell	237 -10	-4%	-$1.34K	0.02%	356
2015 Q4	$34K	Buy	+247	New	+$34K	0.02%	325

Other funds holding ELV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MIHAS

Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Versant Capital Management's ELV Position: Q2 2026 in Review

Versant Capital Management increased its Elevance Health (ELV) stake by 19% in Q2 2026, buying an estimated $78.6K and bringing the position to 1,340 shares worth $518K. The position accounts for 0.05% of the portfolio, ranked #284.

Versant Capital Management first reported a position in ELV in Q4 2015 and has held it in 43 quarters since. 330 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Versant Capital Management held 1,340 shares of Elevance Health worth $518K as of Q2 2026.
Versant Capital Management bought 212 Elevance Health shares in Q2 2026, an estimated $78.6K.
Elevance Health made up 0.05% of Versant Capital Management's portfolio in Q2 2026, its #284 holding.
Versant Capital Management first reported a position in Elevance Health in Q4 2015 and has held it in 43 quarters since.
330 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.